Synteny
PrivateLast Round
Grant
Mar 1, 2024
Total Funding Raised
$3.17M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synteny operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in March 2024.
Synteny is a biotechnology company that develops an AI-driven platform for decoding molecular recognition to design precision TCR bispecific therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synteny Comparables
Compare Synteny with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 3T Biosciences | 84% | |
| Cradle | 78% | |
| Nabla Bio | 78% |
For institutional investors. Book with your work email.
Synteny Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2024 | ||||
| Series A | Oct 1, 2023 |
For institutional investors. Book with your work email.
Synteny Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Obvious Ventures | Series A |
| Amplifyher Ventures | Series A |
| Innovate UK | Grant |
| Black Opal Ventures | Series A |
| In-Q-Tel | Series A |
| Springboard Health Angels | Series A |
| MMC Ventures | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 141% MoM, reaching 3.1K.
- Jul 18, 2026
Grew 16% QoQ, from 19 to 22 employees.
For institutional investors. Book with your work email.
Synteny Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synteny's valuation, stock price, and market status.
Is Synteny a public or private company?
Synteny is a private company.
What is the current stock price of Synteny?
Synteny is a private company, so its shares have no public market price. Caplight tracks Synteny's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synteny worth (valuation)?
Valuation information for Synteny is not publicly available.
Can I buy Synteny stock?
Synteny shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synteny's last funding round?
Synteny's most recent funding round was Grant on March 1, 2024.
Who are the main investors in Synteny?
Key investors in Synteny include Obvious Ventures, Amplifyher Ventures, Innovate UK, Black Opal Ventures, In-Q-Tel.
Will Synteny IPO soon?
No public IPO plans have been announced for Synteny.
How can I track Synteny secondary market activity?
Caplight tracks bids, offers, and trades in Synteny's shares on secondary markets.